Skip to main content
Premium Trial:

Request an Annual Quote

Senate Maintains NIH's 3 Percent Boost for 2009

NEW YORK (GenomeWeb News) – The Senate yesterday passed on to the White House an appropriations bill that will fund much of the Federal Government for the remainder of fiscal 2009 that includes the expected funding increases for several scientific research agencies.

Despite intense argument in the Senate about the thousands of earmarks in the bill, the $410 billion omnibus bill passed without amendments by a vote of 62 to 35.

As GenomeWeb Daily News reported when the House of Representatives passed the bill, it includes $30.3 billion for the National Institutes of Health. That is an increase of $938 million over 2008. The Centers for Disease Control and Prevention will receive $6.6 billion, an increase of $239 million.

The National Institutes of Standards and Technology will receive $819 million, and the Department of Energy's Office of Science will receive $4.8 billion, with $1.2 billion for the DOE's Energy Efficiency and Renewable Energy Programs.

The Food and Drug Administration will receive a $335 million boost up to $2 billion, while $972 million would go to the Food Safety and Inspection Service, an increase of $41 million from the 2008 budget.

President Obama today called the spending bill "imperfect" but said he will sign it.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.